UCB announced that the USFDA has approved Nayzilam (midazolam) nasal spray for the acute treatment o

To all departments and employees:According to the related national legal & the actual situation

On April 29, 2019，the anti-AIDS long-acting two-party “cabotegravir + Ripirilin”submitted to the FDA

Today, the US FDA announced that it has approved the listing of the antiviral therapy Dovato (dolute

Recently, US FDA announced approved the listing of Mayzent (siponimod) developed by Novartis, for th

Jichang Xiao, researcher at Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, ha

Recently, Professor Feng Chao of the Institute of Advanced Synthesis of Nanjing University of Techno

Recently, LOXO Oncology and Bayer jointly announced that the FDA has accelerated the approval of a c

Today, the US FDA announced the approval of the new anti-influenza drug Xofluza (baloxavir marboxil)

Pancreatic cancer is the fourth leading cause of cancer-related deaths with a 5-year survival rate o